Home
ANIP
ANIP News

Latest ANI Pharmaceuticals Inc. (ANIP) News on December 18, 2024

MT Newswires

7 days ago

Leerink Partners Initiates ANI Pharmaceuticals at Outperform With $80 Price Target

Argus Research

8 days ago

ANIP: Raising target price to $62.00

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Zacks

12 days ago

Are Medical Stocks Lagging Adagene (ADAG) This Year?

Argus Research

15 days ago

ANIP: Lowering target price to $60.00

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

16 days ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

MT Newswires

19 days ago

Ani Pharmaceuticals Insider Sold Shares Worth $1,941,442, According to a Recent SEC Filing

Argus Research

22 days ago

ANIP: Raising target price to $61.00

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

GlobeNewswire

22 days ago

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?

Zacks

22 days ago

Does ANI (ANIP) Have the Potential to Rally 31.31% as Wall Street Analysts Expect?

ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

a month ago

ANI (ANIP) Upgraded to Buy: What Does It Mean for the Stock?

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

Zacks

a month ago

Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?

MT Newswires

a month ago

Ani Pharmaceuticals Insider Sold Shares Worth $375,050, According to a Recent SEC Filing

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Zacks

a month ago

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Argus Research

a month ago

ANIP: Raising target price to $64.00

ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

a month ago

ANI Pharmaceuticals Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

GuruFocus.com

a month ago

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics

Zacks

a month ago

Compared to Estimates, ANI (ANIP) Q3 Earnings: A Look at Key Metrics

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates

Zacks

a month ago

ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Surpass Estimates

MT Newswires

a month ago

ANI Pharmaceuticals' Q3 Adjusted Earnings, Net Revenue Rise; Fiscal 2024 Outlook Lifted

Associated Press Finance

a month ago

ANI: Q3 Earnings Snapshot

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire

a month ago

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect

GuruFocus.com

a month ago

ANI Pharmaceuticals Inc (ANIP) Q3 2024 Earnings Report Preview: What To Expect

Argus Research

a month ago

ANIP: Lowering target price to $60.00

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

GlobeNewswire

a month ago

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline

Zacks

2 months ago

Earnings Preview: ANI Pharmaceuticals (ANIP) Q3 Earnings Expected to Decline

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

GlobeNewswire

2 months ago

ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET

MT Newswires

2 months ago

ANI Pharmaceuticals Launches Estradiol Gel Following US FDA's Final Approval for Abbreviated New Drug Application

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

GlobeNewswire

2 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

GlobeNewswire

2 months ago

ANI Pharmaceuticals to Present New Data Highlighting Membranous Nephropathy Research at American Society of Nephrology Kidney Week 2024

ANI Pharmaceuticals price target raised to $62 from $60 at Truist

TipRanks

2 months ago

ANI Pharmaceuticals price target raised to $62 from $60 at Truist

MT Newswires

2 months ago

Truist Raises Price Target on ANI Pharmaceuticals to $62 From $60, Keeps Hold Rating

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

2 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Zacks

2 months ago

Are Medical Stocks Lagging Alnylam Pharmaceuticals (ALNY) This Year?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

2 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Simply Wall St.

2 months ago

ANI Pharmaceuticals, Inc.'s (NASDAQ:ANIP) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks

2 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

Zacks

2 months ago

Will ANI (ANIP) Beat Estimates Again in Its Next Earnings Report?

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug

Zacks

2 months ago

RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug

Benzinga

2 months ago

ANI Pharmaceuticals Shifts Focus From Generics To High-Margin Brand Assets, Analyst Sees Strong Potential

MT Newswires

2 months ago

Piper Sandler Initiates Coverage on ANI Pharmaceuticals With Overweight Rating, $68 Price Target

Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know

Zacks

2 months ago

Wall Street Analysts Predict a 42.98% Upside in ANI (ANIP): Here's What You Should Know

Argus Research

2 months ago

ANIP: Lowering target price to $60.00

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Zacks

3 months ago

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

MT Newswires

3 months ago

Sector Update: Health Care Stocks Edge Higher Premarket Thursday

MT Newswires

3 months ago

ANI Pharmaceuticals Says FDA Approved Generic Version of Nizoral Anti-Dandruff Shampoo

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

GlobeNewswire

3 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Ketoconazole Shampoo, 2%

MT Newswires

3 months ago

ANI Pharmaceuticals Completes Purchase of Alimera Sciences, Sees 'Substantially Higher' Earnings After Deal

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

GlobeNewswire

3 months ago

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

GlobeNewswire

3 months ago

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

MT Newswires

3 months ago

ANI Pharmaceuticals Launches Oral Solution of Promethazine Hydrochloride and Dextromethorphan Hydrobromide

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

GlobeNewswire

3 months ago

ANI Pharmaceuticals Launches Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?

Zacks

3 months ago

Alimera Sciences (ALIM) Soars 6.6%: Is Further Upside Left in the Stock?

MT Newswires

3 months ago

ANI Pharmaceuticals, Alimera Sciences to Close Merger Next Week

Business Wire

3 months ago

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

MT Newswires

3 months ago

Alimera Sciences Sues ANI Pharmaceuticals for Delays in Merger Close

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

GlobeNewswire

3 months ago

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

ANI Pharmaceuticals, Inc. (ANIP): A Cheap Pharmaceutical Stock to Buy According to Short Sellers

Insider Monkey

4 months ago

ANI Pharmaceuticals, Inc. (ANIP): A Cheap Pharmaceutical Stock to Buy According to Short Sellers

Argus Research

4 months ago

ANIP: Raising target price to $66.00

Argus Research

4 months ago

ANIP: Raising target price to $64.00

Are Medical Stocks Lagging Argenx (ARGX) This Year?

Zacks

4 months ago

Are Medical Stocks Lagging Argenx (ARGX) This Year?

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

Zacks

4 months ago

Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?

ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Of Questionable Quality

Simply Wall St.

4 months ago

ANI Pharmaceuticals' (NASDAQ:ANIP) Earnings Are Of Questionable Quality

MT Newswires

4 months ago

ANI Pharmaceuticals Raises $316.25 Million From Convertible Senior Notes Offering

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

GlobeNewswire

4 months ago

ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes

ANI Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

4 months ago

ANI Pharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

MT Newswires

4 months ago

ANI Pharmaceuticals Prices Upsized $275 Million Senior Notes Offering

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

GlobeNewswire

4 months ago

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

MT Newswires

4 months ago

ANI Pharmaceuticals Plans Convertible Senior Notes Offering

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

GlobeNewswire

4 months ago

ANI Pharmaceuticals, Inc. Announces Proposed Convertible Senior Notes Offering

MT Newswires

4 months ago

Sector Update: Health Care Stocks Rise Late Afternoon

MT Newswires

4 months ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

MT Newswires

4 months ago

ANI Pharmaceuticals Shares Rise After Q2 Beat; Full Year 2024 Guidance Lifted

Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics

Zacks

4 months ago

Compared to Estimates, ANI (ANIP) Q2 Earnings: A Look at Key Metrics

ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates

Zacks

4 months ago

ANI Pharmaceuticals (ANIP) Tops Q2 Earnings and Revenue Estimates

Associated Press Finance

4 months ago

ANI: Q2 Earnings Snapshot

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

GlobeNewswire

4 months ago

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

Seeking Clues to ANI (ANIP) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

Zacks

4 months ago

Seeking Clues to ANI (ANIP) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET

GlobeNewswire

5 months ago

ANI Pharmaceuticals to Discuss Second Quarter 2024 Financial Results on August 6, 2024, at 8:30 a.m. ET

Argus Research

5 months ago

ANIP: Raising target price to $68.00

Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why

Zacks

5 months ago

Syros (SYRS) Stock Rises More Than 35% in 3 Months: Here's Why

Argus Research

5 months ago

ANIP: Raising target price to $67.00

MT Newswires

5 months ago

ANI Pharmaceuticals Launches L-Glutamine Oral Powder Following FDA Approval

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

GlobeNewswire

5 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of L-Glutamine Oral Powder

Argus Research

5 months ago

ANIP: Lowering target price to $64.00

MT Newswires

6 months ago

ANI Pharmaceuticals Receives FDA Approval for Naproxen Delayed-Release Tablets

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

GlobeNewswire

6 months ago

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

MT Newswires

6 months ago

HC Wainwright Adjusts ANI Pharmaceuticals Price Target to $94 From $87, Maintains Buy Rating

Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals

Zacks

6 months ago

Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals

ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

GlobeNewswire

6 months ago

ANI Pharmaceuticals’ CEO Nikhil Lalwani Named EY Entrepreneur Of The Year® 2024 New Jersey Award Winner

MT Newswires

6 months ago

Top Midday Gainers

Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal

Benzinga

6 months ago

Generics Player ANI Pharmaceuticals Strengthens Rare Disease Segment With $380M Alimera Sciences Deal

Alimera Sciences shares jump by 77% after being acquired by ANI

Pharmaceutical Technology

6 months ago

Alimera Sciences shares jump by 77% after being acquired by ANI

MT Newswires

6 months ago

ANI Pharmaceuticals to Acquire Alimera Sciences in $381 Million Deal

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

GlobeNewswire

6 months ago

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

ANI Pharmaceuticals (NASDAQ:ANIP) shareholders are still up 77% over 3 years despite pulling back 6.5% in the past week

Simply Wall St.

6 months ago

ANI Pharmaceuticals (NASDAQ:ANIP) shareholders are still up 77% over 3 years despite pulling back 6.5% in the past week

Strength Seen in Gilead (GILD): Can Its 8.5% Jump Turn into More Strength?

Zacks

6 months ago

Strength Seen in Gilead (GILD): Can Its 8.5% Jump Turn into More Strength?

MT Newswires

6 months ago

Ani Pharmaceuticals Insider Sold Shares Worth $1,817,663, According to a Recent SEC Filing

Implied Volatility Surging for ANI Pharmaceuticals (ANIP) Stock Options

Zacks

6 months ago

Implied Volatility Surging for ANI Pharmaceuticals (ANIP) Stock Options

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

6 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

6 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share on Social Networks: